HST Bulletin
There are currently
200 guests
online.
Search in:
All
News
Projects
Publications
Home
About Us
Vision, Mission and Values
Structure and Governance
How we are Organised
Health Systems Research
Health Systems Strengthening
Corporate Services
Our Team
HST Executive Team
HST Interns
HST History
Board of Trustees
HST Brief Profile
Annual Reports
Annual Financial Statements
Our Achievements
HST Employment
Projects
Current Projects
Archived Projects
Publications
South African Health Review
SAHR 2012/13
SAHR 2011
SAHR 2010
SAHR 2008
SAHR 2007
SAHR 2006
SAHR 2005
SAHR 2003/04
SAHR 2002
SAHR 2001
SAHR 2000
SAHR 1999
SAHR 1998
SAHR 1997
SAHR 1996
SAHR 1995
District Health Barometer
DHB 2011/12
DHB 2010/11
DHB 2008/09
DHB 2007/08
DHB 2006/07
DHB 2005/06
DHB 2004
All HST Publications
Non-HST Publications
HST Bulletin
Kwik Skwiz
HST Updates
Research Snapshots
Useful Links
Health Indicators
Indicators
Advanced Search
Indicator Definitions
Key References
Recently Updated Indicators
Contact Us
Cape Town Office
Durban (Head Office)
Midrand Office
Sattelite Offices
Eastern Cape
Mthatha Office
Free State
Bloemfontein Office
Sasolburg Office
Welkom Office
KwaZulu-Natal
Dundee Office
Ladysmith Office
Pietermartizburg Office
Limpopo
Modimolle Office
Northern Cape
DeAar Office
Kimberley Office
Sulfonamides
New drug could help patients resistant to existing ARVs
Barcelona
Biology
CDATA
Darunavir
Entertainment
Entertainment
Eric Goemaere
FDA
Head
head of programme in South Africa
HIV/AIDS
Immunodeficiency
Médecins Sans Frontières
Medecins Sans Frontieres
Medicine
Microbiology
Person Career
Protease inhibitors
Ritonavir
Sexually transmitted diseases and infections
Social Issues
Social Issues
South Africa
Sulfonamides
A new HIV drug has shown promising results when used in conjunction with existing combination therapy and could increase the options for those developing resistance to treatment.
Read more